A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Common Warts
Public ClinicalTrials.gov record NCT01286441. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Multi-center, Placebo-controlled, Dose-ranging, Efficacy and Safety Trial of a New Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) for Treatment of Common Warts (Verruca Vulgaris)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Nonclinical studies have shown sandalwood oil to have anti-inflammatory, anti-fungal, antiviral, and anti-bacterial activities. Previous clinical studies have shown East Indian Sandalwood oil to be promising as a treatment for common warts in adults and children. The primary objective of this study is to evaluate the efficacy and safety of 10%, 20%, and 30% East Indian Sandalwood Oil (EISO) ointment compared with the ointment placebo administered twice daily (bid) for 12 weeks for the treatment of common warts (Verruca vulgaris).
Study identification
- NCT ID
- NCT01286441
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 183 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2012 (Type not available)
- Primary completion
- Apr 2014 (Actual)
- Completion
- Jun 2014 (Actual)
- Last update posted
- May 29, 2019
2012 – 2014
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Rogers | Arkansas | 72758 | — |
| Not listed | Fremont | California | 95438 | — |
| Not listed | Lomita | California | 90717 | — |
| Not listed | Miami | Florida | 33135 | — |
| Not listed | Arlington Heights | Illinois | 60005 | — |
| Not listed | Elwood | Indiana | 46036 | — |
| Not listed | Owensboro | Kentucky | 42303 | — |
| Not listed | Beverly | Massachusetts | 01915 | — |
| Not listed | Haverhill | Massachusetts | 01830 | — |
| Not listed | Fort Gratiot | Michigan | 48059 | — |
| Not listed | Newington | New Hampshire | 03801 | — |
| Not listed | Portsmouth | New Hampshire | 03801 | — |
| Not listed | Rochester | New York | 14623 | — |
| Not listed | Raleigh | North Carolina | 27612 | — |
| Not listed | Salisbury | North Carolina | 28144 | — |
| Not listed | Columbus | Ohio | 43231 | — |
| Not listed | College Station | Texas | 77845 | — |
| Not listed | Dallas | Texas | 75234 | — |
| Not listed | San Antonio | Texas | 78258 | — |
| Not listed | Virginia Beach | Virginia | 23455 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01286441, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 29, 2019 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01286441 live on ClinicalTrials.gov.